http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7371399-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a02b9a4956c3a50493cc6846071cd978
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30
filingDate 2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf99a2158e46b3c59ed1131dca9f179
publicationDate 2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7371399-B2
titleOfInvention Polymer gel containing hyaluronic acid and collagen, and its use in joints
abstract Formulations and methods for treating joints, such as temporomandibular joint disorders, osteoarthritis of the knee, hip and other types of inflammatory joint diseases. The method involves identifying specific matrix metalloproteinases (MMPs) that may be responsible for degrading the soft tissues of the joint in question, identifying the specific component of the joint the MMP(s) are targeting, and injecting a polymer gel with the component the MMP(s) seek to destroy, thus preserving the joint and allowing time to heal. These formulations typically require a mixture of glycosoaminoglycans and collagen proteins. One formulation in particular includes both hyaluronic acid and at least type I collagen.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013142254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101422689-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3896152-A1
priorityDate 2004-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4636524-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4472376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5137875-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128590101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148431
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135772871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396789

Total number of triples: 30.